≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Prostate

Endpoint Browser

CD2_BENIGN_PROSTATE_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

only males

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D29.1&
  • Hospital discharge: ICD-9 — 2222
  • Cause of death: ICD-10 — D29.1&
  • Cause of death: ICD-9 — 2222

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D29
Name in latin
Neoplasma benignum prostatae

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 225 - 225
Unadjusted period prevalence (%) 0.10 - 0.10
Median age at first event (years) 67.88 - 67.88

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
206
Matched controls
2060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D29.1
ICD-10 Finland
Benign neoplasm: Prostate
4503599627370496.0
286.7
203
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
113.2
98
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
403.2
111.9
103
5
116
Kela drug reimbursment
Prostate cancer
+∞
60.4
55
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
37.7
35
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
428.1
37.2
36
*
ZXC96
NOMESCO Finland
Robot assisted procedure
+∞
34.3
32
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
32.1
30
*
Y77
ICPC
Malignant neoplasm prostate
+∞
31.0
29
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
17.3
26.3
42
30
L02BB03
ATC
bicalutamide; oral
+∞
25.5
24
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
10.8
21.7
43
49
UKC02
NOMESCO Finland
Cystoscopy
4.4
18.4
81
264
XKD00
NOMESCO Finland
Uroflowmetry
3.9
16.2
85
316
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
15.8
15
*
130
Kela drug reimbursment
Malignant tumour
+∞
14.8
14
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
14.8
14
*
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
4.2
14.4
62
192
XJH00
NOMESCO Finland
Transanal ultrasonography
5.3
14.2
46
106
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
13.7
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
11.3
117
658
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.3
11.1
66
258
N40
ICD-10 Finland
Hyperplasia of prostate
2.7
10.7
125
747
WF002
NOMESCO Finland
Radical radiotherapy
+∞
10.5
10
*
JN4AD
NOMESCO Finland
Body CT examination
8.9
10.1
21
26
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.9
10.0
43
130
H02AB02
ATC
dexamethasone; systemic
31.7
9.5
12
*
TKE00
NOMESCO Finland
Needle biopsy of prostate
6.9
9.4
23
37
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
9.1
62
262
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
9.0
59
243
R31
ICD-10 Finland
Unspecified haematuria
3.3
8.9
49
180
KCD02
NOMESCO Finland
Transurethral resection of bladder
52.2
8.8
10
*
Z51.5
ICD-10 Finland
Palliative care
10.7
8.7
16
16
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
28.9
8.6
11
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
8.4
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
8.4
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.4
8
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
8.4
8
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
34.8
8.2
10
*
B01AB05
ATC
enoxaparin; parenteral
2.6
8.1
69
332
R33
ICD-10 Finland
Retention of urine
3.2
7.5
41
148
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
L02BX02
ATC
degarelix; parenteral
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.7
7.2
31
94
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
4.8
6.4
20
45
C05AA08
ATC
fluocortolone; rectal, topical
3.1
6.3
35
127
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
6.3
6
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
6.3
6
*
G03HA01
ATC
cyproterone; systemic
+∞
6.3
6
*
TKE10
NOMESCO Finland
Puncture of prostate
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
6.3
6
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
JN4BD
NOMESCO Finland
Extensive body CT
4.5
6.2
21
51

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
58
175
4.12
17.46
6.9
3.9
—
—
—
0
0
87
417
2.77
11.79
2.4
1.6
—
—
—
0
0
16
22
7.75
11.13
1.0
1.1
—
—
—
0
0
31
93
3.71
9.15
5.7
5.3
23.6
24.8
mmol/l
1.25
26
87
26
70
4.07
8.90
1.8
1.9
1.2
2.0
ug/l
0.37
16
61
21
48
4.72
8.82
1.2
1.2
—
—
—
0
0
101
584
2.32
8.64
5.7
4.5
—
—
—
0
0
33
109
3.38
8.41
1.2
1.1
—
—
—
0
0
86
484
2.26
7.65
2.7
2.3
—
—
—
0
0
26
78
3.64
7.65
2.6
1.8
—
—
—
0
0
155
1107
2.29
7.58
5.9
3.7
—
—
—
0
0
181
1386
2.56
7.47
8.4
4.2
2.9
2.1
ug/l
0.44
151
1224
120
797
2.08
6.78
7.2
11.9
1.2
1.4
inr
1.43
25
212
18
46
4.17
6.58
1.8
1.7
—
—
—
0
0
36
146
2.74
6.42
5.3
4.4
4.8
5.1
kpa
1.10
31
134
28
102
2.99
6.05
2.3
3.2
3.8
3.8
e9/l
0.00
15
67
30
114
2.88
6.02
5.2
4.5
—
—
—
0
0
88
546
2.00
5.76
4.0
3.9
—
—
—
0
0
90
586
1.89
4.97
3.0
2.2
460.3
373.1
u/l
0.14
85
535
157
1228
1.92
4.78
8.2
5.1
77.7
76.6
u/l
0.12
147
1121
29
125
2.52
4.57
4.0
1.3
—
—
—
0
0
108
762
1.80
4.50
7.5
5.7
1.2
1.2
mmol/l
0.04
85
667
89
1216
0.56
4.35
3.9
4.5
—
—
—
0
0
79
514
1.83
4.25
5.3
4.9
—
—
—
0
0
11
29
3.94
3.85
2.5
1.2
—
—
—
0
0
11
29
3.94
3.85
2.5
3.1
—
—
—
0
0
10
25
4.14
3.74
2.3
1.8
—
—
—
0
0
98
702
1.70
3.67
5.4
5.3
8.8
9.2
%
0.53
86
647
12
35
3.57
3.67
3.2
1.2
—
—
—
0
0
99
713
1.69
3.62
5.3
5.2
23.8
24.5
%
0.23
85
656
35
183
2.08
3.53
4.1
3.1
—
—
—
0
0
97
701
1.67
3.47
5.1
5.0
2.7
3.1
%
1.30
85
648
33
170
2.10
3.46
2.1
2.2
9.7
14.7
nmol/l
2.35
22
146
99
1267
0.61
3.28
26.3
20.0
332.7
333.7
g/l
0.43
99
1256
25
474
0.47
3.27
2.5
3.4
—
—
—
0
0
96
709
1.62
3.06
4.8
5.0
60.6
59.3
%
0.52
83
658
9
21
4.42
3.03
4.9
6.4
12.9
11.9
mg/l
—
9
21
29
151
2.06
2.96
3.9
1.9
64.3
67.0
g/l
1.07
22
133
93
687
1.60
2.94
5.4
4.9
0.6
0.6
%
0.05
81
641
85
619
1.60
2.83
2.8
2.6
210.2
190.5
ug/l
0.23
73
556
111
861
1.57
2.82
6.3
5.5
5.0
4.6
e9/l
0.80
98
755
104
795
1.57
2.81
4.6
4.2
35.2
54.7
ng/l
1.39
87
629
15
60
2.61
2.76
1.1
1.3
—
—
—
0
0
22
106
2.19
2.73
1.9
1.4
—
—
—
0
0
6
10
6.13
2.71
2.3
1.3
—
—
—
0
0
8
19
4.32
2.70
3.0
4.3
—
—
—
0
0
182
1596
1.73
2.70
21.1
14.7
27.3
29.4
mg/l
0.35
155
1277
98
750
1.54
2.58
4.6
2.8
0.7
0.8
ug/l
0.43
76
534
103
798
1.54
2.56
2.2
2.1
101.6
89.0
pmol/l
1.13
54
452
6
11
5.57
2.56
3.2
2.3
—
—
—
0
0
14
57
2.55
2.50
1.2
1.3
35.9
35.8
g/l
—
9
44
103
802
1.52
2.48
5.0
4.8
0.2
0.2
e9/l
1.55
85
697
144
1205
1.54
2.47
5.2
3.8
15.6
12.8
mm/h
0.91
126
1067
24
125
2.03
2.46
1.9
1.5
—
—
—
0
0
7
17
4.21
2.38
1.3
1.1
—
—
—
0
0
50
703
0.63
2.20
9.1
8.2
0.0
0.0
e9/l
0.50
39
581
98
773
1.47
2.14
4.8
4.7
0.6
0.6
e9/l
0.15
83
664
34
209
1.74
2.13
2.2
2.2
69.1
64.6
e9/l
0.43
27
166
98
778
1.46
2.05
4.8
4.7
0.0
0.0
e9/l
0.39
83
678
5
11
4.62
1.95
3.0
1.4
3.1
2.2
u/ml
—
5
11
20
107
1.95
1.93
1.9
1.5
—
—
—
0
0
190
1729
1.64
1.93
25.6
18.8
139.5
139.7
mmol/l
0.39
178
1667
19
101
1.96
1.87
2.5
3.0
—
—
—
0
0
190
1734
1.62
1.85
25.8
18.8
4.0
4.1
mmol/l
0.21
178
1673
6
17
3.60
1.85
1.2
1.4
—
—
—
0
0
39
259
1.61
1.85
2.6
2.5
2.1
2.2
g/l
0.55
33
237
37
246
1.60
1.75
2.8
2.6
21.1
24.2
%
0.65
31
209
97
788
1.41
1.72
4.9
4.8
1.7
1.7
e9/l
0.44
81
684
32
207
1.64
1.68
2.1
1.9
—
—
—
0
0
5
132
0.36
1.68
9.4
2.8
—
—
—
0
0
191
1758
1.57
1.64
30.5
21.7
230.1
223.1
e9/l
0.82
180
1689
191
1758
1.57
1.64
30.4
21.6
91.8
92.3
fl
0.63
183
1709
58
432
1.46
1.64
1.8
1.9
1079.0
1160.2
nmol/l
0.21
36
334
191
1759
1.57
1.63
30.6
21.7
7.3
7.0
e9/l
1.16
179
1685
191
1759
1.57
1.63
30.4
21.6
30.5
30.8
pg
1.51
183
1710
191
1759
1.57
1.63
30.6
21.8
134.0
137.6
g/l
2.07
183
1710
191
1759
1.57
1.63
30.5
21.7
4.4
4.5
e12/l
0.74
177
1681
64
489
1.43
1.58
1.9
2.0
3.1
2.9
mg/l
0.23
51
415
58
435
1.45
1.58
3.4
2.9
—
—
—
0
0
161
1442
1.41
1.51
4.4
3.8
2.0
2.1
mu/l
0.15
125
1253
65
502
1.41
1.51
3.5
2.7
7611.4
9157.0
umol/l
0.07
53
426
23
142
1.69
1.45
2.2
1.5
—
—
—
0
0
10
46
2.23
1.42
1.5
1.2
—
—
—
0
0
41
295
1.48
1.38
2.8
2.5
10.5
13.1
umol/l
1.55
35
268
5
17
2.98
1.36
1.4
1.3
17.2
15.8
ug/l
—
5
17
6
24
2.54
1.31
1.3
1.1
—
—
—
0
0
25
163
1.60
1.30
1.2
1.2
226.7
379.4
titre
—
6
31
10
48
2.13
1.29
1.1
1.5
—
—
—
0
0
32
222
1.51
1.28
1.8
2.6
5.0
8.3
ug/l
1.07
22
191
63
501
1.36
1.21
1.8
1.6
17.7
18.4
nmol/l
0.11
48
420
174
1602
1.38
1.21
5.1
5.0
4.2
4.2
mmol/l
0.03
136
1447
37
270
1.44
1.16
2.2
2.0
1.9
1.7
%
0.42
31
238
5
20
2.53
1.15
1.0
1.4
—
—
—
0
0
21
312
0.64
1.14
4.7
3.6
—
—
—
0
0
167
1534
1.34
1.13
4.8
4.5
1.3
1.3
mmol/l
0.20
130
1363
177
1643
1.36
1.10
5.6
5.7
2.4
2.4
mmol/l
0.05
142
1482
8
41
1.99
1.10
3.4
3.3
0.7
0.9
nmol/l
—
8
32
173
1601
1.35
1.09
6.1
5.3
6.1
6.2
mmol/l
1.23
134
1423
178
1657
1.36
1.06
22.5
14.5
—
—
—
0
0
5
22
2.30
1.04
4.6
1.4
90.5
89.2
%
—
5
22
9
48
1.91
1.01
2.1
2.6
—
—
—
0
0
122
1086
1.27
0.99
3.1
2.9
15.3
15.1
pmol/l
0.36
93
939
5
23
2.20
0.98
1.0
1.0
—
—
—
0
0
7
36
1.97
0.98
1.1
1.1
—
—
—
0
0
26
184
1.47
0.97
1.2
1.5
—
—
—
0
0
11
62
1.81
0.96
1.1
1.4
—
—
—
0
0
85
727
1.27
0.95
5.3
3.8
33.6
34.6
g/l
0.70
73
675
24
168
1.48
0.94
5.2
8.5
—
—
—
0
0
63
522
1.29
0.90
2.7
2.2
2.3
2.3
mmol/l
0.12
46
421
6
29
2.10
0.90
1.2
1.1
—
—
—
0
0
181
1702
1.32
0.90
12.4
9.2
25.4
25.8
u/l
0.10
165
1607
16
104
1.58
0.87
2.2
2.4
—
—
—
0
0
13
80
1.66
0.86
1.3
1.4
—
49.0
—
0
5
56
462
1.28
0.83
4.2
2.7
—
—
—
0
0
169
1583
1.27
0.81
5.8
5.0
1.3
1.3
mmol/l
0.16
135
1419
43
347
1.30
0.75
5.2
4.2
—
—
—
0
0
15
100
1.54
0.75
3.9
3.7
2.3
0.2
%
—
6
21
20
143
1.44
0.73
1.3
1.3
—
—
—
0
0
34
268
1.32
0.71
2.2
1.9
—
—
—
0
0
7
41
1.73
0.70
1.1
1.1
—
—
—
0
0
144
1336
1.22
0.70
19.2
16.4
40.1
39.4
%
0.27
74
769
166
1565
1.23
0.67
7.7
7.1
41.3
41.8
mmol/mol
0.25
126
1423
12
78
1.57
0.67
1.1
1.3
—
—
—
0
0
30
376
0.77
0.65
4.9
3.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.8
—
565.5
—
0
13
8
55
1.47
0.56
1.9
3.1
22.8
24.7
mmol/l
—
8
47
8
55
1.47
0.56
1.5
1.7
—
—
—
0
0
6
37
1.64
0.56
7.2
3.4
—
—
—
0
0
6
38
1.59
0.54
1.2
1.2
12.3
22.0
u/l
—
6
32
15
109
1.40
0.52
3.9
3.6
0.1
0.1
%
—
7
26
12
167
0.70
0.51
1.8
1.5
—
—
—
0
0
11
76
1.47
0.49
1.5
1.3
—
—
—
0
0
12
85
1.43
0.48
2.3
3.8
—
—
—
0
0
25
202
1.27
0.46
2.3
3.4
—
—
—
0
0
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
2.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
15
115
1.33
0.40
4.0
3.5
1.0
1.0
%
—
7
32
24
197
1.24
0.39
1.3
1.2
1.2
13.1
u/ml
—
7
55
24
198
1.24
0.38
2.3
3.5
1.9
1.6
mmol/l
0.15
18
161
31
362
0.83
0.38
5.9
4.0
1.0
1.0
kg/l
—
6
49
26
217
1.22
0.37
1.3
1.2
12.0
38.3
iu/ml
—
6
60
9
125
0.71
0.36
3.9
2.6
1.2
1.2
mmol/l
—
9
105
54
594
0.88
0.32
4.3
3.4
—
—
—
0
0
42
375
1.15
0.30
4.0
3.7
—
—
—
0
0
54
492
1.13
0.29
4.9
2.7
0.2
0.5
e6/l
1.72
45
363
59
541
1.12
0.29
4.9
2.9
76.7
230.6
e6/l
0.58
50
414
8
67
1.20
0.26
23.6
13.1
—
—
—
0
0
23
200
1.17
0.23
2.4
3.5
5.7
5.8
kpa
0.19
23
193
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
12
99
1.22
0.20
4.6
3.7
0.0
0.0
%
—
6
22
41
445
0.90
0.20
4.6
3.7
0.0
0.0
estimate
0.00
11
122
24
213
1.14
0.19
1.6
1.2
2.4
3.3
g/l
1.61
17
134
7
61
1.15
0.17
1.1
1.3
—
—
—
0
0
8
71
1.13
0.16
1.8
1.7
38.0
45.3
nmol/l
—
8
65
8
98
0.81
0.14
4.6
3.8
—
—
—
0
0
41
384
1.08
0.14
1.2
1.3
—
—
—
0
0
8
99
0.80
0.14
7.6
10.9
—
—
—
0
0
65
674
0.95
0.10
5.1
4.2
25.5
8.8
mg/mmol
0.54
43
453
33
347
0.94
0.08
3.1
2.3
546.5
589.0
mosm/kgh2o
0.59
28
271
62
635
0.97
0.05
4.4
3.4
110.5
224.8
mg/l
0.41
40
439
65
635
1.03
0.05
4.2
3.3
7.8
8.0
mmol/l
0.13
48
524
18
169
1.07
0.05
2.3
2.9
5.5
4.5
kpa
0.34
18
161
76
748
1.02
0.03
4.4
3.5
0.0
0.0
estimate
0.00
12
132
76
748
1.02
0.03
5.3
4.6
0.0
0.0
estimate
0.00
12
132
26
252
1.04
0.02
5.5
7.0
104.8
104.7
mmol/l
0.03
26
247
61
601
1.02
0.02
5.6
3.2
84.2
83.7
e6/l
0.00
51
439
77
763
1.01
0.01
4.5
3.5
0.0
0.0
estimate
0.00
11
125
10
102
0.98
0.00
1.5
2.7
1.2
1.1
%
—
10
102
12
119
1.01
0.00
1.2
1.5
—
—
—
0
0
25
246
1.02
0.00
4.9
6.9
0.4
1.2
mmol/l
0.39
20
183
16
161
0.99
0.00
2.9
3.7
—
—
—
0
0
20
203
0.98
0.00
1.4
1.2
—
—
—
0
0
32
325
0.98
0.00
1.7
1.6
1.4
1.7
mg/l
0.29
23
255
46
462
0.99
0.00
5.8
3.4
7.4
7.4
ph
—
8
76
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
7.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
0.2
—
0
8
45
450
1.00
0.00
1.6
1.8
176471050.9
26722158.8
pmol/l
0.39
34
363
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
77.0
—
0
5
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
3.6
—
0
5
0
5
0.00
0.00
0.0
6.2
—
25.8
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_PROSTATE_EXALLC – Benign neoplasm: Prostate

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).